deltatrials
Completed PHASE4 NCT00693251

Optimal Stenting Strategy For True Bifurcation Lesions

Phase IV Study of Optimal Stenting Strategy For True Bifurcation Lesions

Sponsor: CardioVascular Research Foundation, Korea

Conditions Coronary Artery Disease
Interventions Crush technique provisional T stenting
Updated 6 times since 2017 Last updated: Nov 16, 2015 Started: Jan 31, 2008 Primary completion: Jun 30, 2015 Completion: Jun 30, 2015

Listed as NCT00693251, this PHASE4 trial focuses on Coronary Artery Disease and remains completed. Sponsored by CardioVascular Research Foundation, Korea, it has been updated 6 times since 2008, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Change History

6 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

Jan 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • CardioVascular Research Foundation, Korea
  • Seung-Jung Park
Data source: CardioVascular Research Foundation, Korea

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Bucheon-si, South Korea
  • • Busan, South Korea
  • • Cheongju-si, South Korea
  • • Chuncheon, South Korea
  • • Daejeon, South Korea
  • • Jinju, South Korea
  • • Pyeongchon, South Korea
  • • Seoul, South Korea
  • • Suwon, South Korea
  • • Ulsan, South Korea